Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Coverage Reform Bills Likely To Resurface Next Session - HIMA

This article was originally published in The Gray Sheet

Executive Summary

Measures aimed at reforming the Medicare coverage process and omitted from Balanced Budget Act revision legislation are likely to reemerge in the next congressional session, Health Industry Manufacturers Association President Pamela Bailey predicted.

You may also be interested in...



HIMAPAC Coffers Reaches $16,000; Funds Flow To 20 Candidates As Of Feb. 1

Device executives at 32 manufacturers contributed a total of $16,000 to the Health Industry Manufacturers Association's Political Action Committee (HIMAPAC) between March 1999 and Feb. 1, 2000.

HIMAPAC Coffers Reaches $16,000; Funds Flow To 20 Candidates As Of Feb. 1

Device executives at 32 manufacturers contributed a total of $16,000 to the Health Industry Manufacturers Association's Political Action Committee (HIMAPAC) between March 1999 and Feb. 1, 2000.

Congress Moves To Adopt $16 Bil. Medicare Funding Restoration Measure

Spending for dialysis and durable medical equipment under the Medicare Balanced Budget Refinement Act (HR 3426) is projected to increase $300 mil. over the next five years, according to estimates prepared by the Congressional Budget Office.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012520

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel